DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nystatin (Nystatin) - Hospitalization - Suspected Cause - Side Effect Reports

 
 



Index of reports > Hospitalization (11)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Nystatin hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Nystatin side effects in male

Reported by a lawyer from United States on 2012-07-12

Patient: male

Reactions: Cleft LIP and Palate, Cerebral Palsy, Torticollis, Craniosynostosis, Lacrimal Disorder, Developmental Delay, Plagiocephaly, Feeding Disorder, Hydrocele, Duane's Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen

Oxycodone / Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Nystatin
    Indication: Foetal Exposure During Pregnancy

Vicodin
    Indication: Foetal Exposure During Pregnancy

Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy

Oxycontin
    Indication: Foetal Exposure During Pregnancy

Ovcon-35
    Indication: Foetal Exposure During Pregnancy

Ultram
    Indication: Foetal Exposure During Pregnancy

Soma
    Indication: Foetal Exposure During Pregnancy

Feldene
    Indication: Foetal Exposure During Pregnancy

Crestor
    Indication: Foetal Exposure During Pregnancy

Effexor
    Indication: Foetal Exposure During Pregnancy

Selective Serotonin Reuptake Inhibitor
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP; Folic Acid; Fish OIL



Possible Nystatin side effects in male

Reported by a consumer/non-health professional from United States on 2012-06-15

Patient: male

Reactions: Cerebral Palsy, Cleft LIP and Palate, Maternal Drugs Affecting Foetus, Ear Infection, Torticollis, Craniosynostosis, Lacrimal Disorder, Developmental Delay, Plagiocephaly, Dacryostenosis Congenital, Hypermetropia, Feeding Disorder, Hydrocele, Duane's Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Oxycontin
    Indication: Foetal Exposure During Pregnancy

Effexor
    Indication: Foetal Exposure During Pregnancy

Vicodin
    Indication: Foetal Exposure During Pregnancy

Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Crestor
    Indication: Foetal Exposure During Pregnancy

Ovcon-35
    Indication: Foetal Exposure During Pregnancy

Nystatin
    Indication: Foetal Exposure During Pregnancy

Selective Serotonin Reuptake Inhibitor
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy

Soma
    Indication: Foetal Exposure During Pregnancy

Feldene
    Indication: Foetal Exposure During Pregnancy

Acetaminophen

Ultram
    Indication: Foetal Exposure During Pregnancy

Oxycodone / Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Leucovorin Calcium; Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP; Fish OIL



Possible Nystatin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-14

Patient: male

Reactions: Cleft LIP and Palate, Torticollis, Craniosynostosis, Lacrimal Disorder, Developmental Delay, Feeding Disorder, Duane's Syndrome, Hydrocele

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Ovcon-35
    Indication: Foetal Exposure During Pregnancy

Soma
    Indication: Foetal Exposure During Pregnancy

Vicodin
    Indication: Foetal Exposure During Pregnancy

Effexor
    Indication: Foetal Exposure During Pregnancy

Acetaminophen

Feldene
    Indication: Foetal Exposure During Pregnancy

Selective Serotonin Reuptake Inhibitor
    Indication: Foetal Exposure During Pregnancy

Ultram
    Indication: Foetal Exposure During Pregnancy

Oxycontin
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy

Oxycodone / Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Crestor
    Indication: Foetal Exposure During Pregnancy

Nystatin
    Indication: Foetal Exposure During Pregnancy

Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Leucovorin Calcium; Fish OIL; Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP



Possible Nystatin side effects in male

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-06

Patient: male

Reactions: Cleft LIP and Palate, Craniosynostosis, Developmental Delay, Torticollis, Feeding Disorder, Hydrocele, Duane's Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Crestor
    Indication: Foetal Exposure During Pregnancy

Feldene
    Indication: Foetal Exposure During Pregnancy

Topamax
    Indication: Foetal Exposure During Pregnancy

Oxycodone / Acetaminophen
    Indication: Foetal Exposure During Pregnancy

Acetaminophen

Selective Serotonin Reuptake Inhibitor
    Indication: Foetal Exposure During Pregnancy

Ovcon-35
    Indication: Foetal Exposure During Pregnancy

Oxycontin
    Indication: Foetal Exposure During Pregnancy

Vicodin
    Indication: Foetal Exposure During Pregnancy

Ultram
    Indication: Foetal Exposure During Pregnancy

Soma
    Indication: Foetal Exposure During Pregnancy

Nystatin
    Indication: Foetal Exposure During Pregnancy

Effexor
    Indication: Foetal Exposure During Pregnancy

Other drugs received by patient: Vitamin and Mineral Prenatal Supplement W / Folic Acid CAP; Folic Acid; Fish OIL



Possible Nystatin side effects in 76 year old female

Reported by a individual with unspecified qualification from United States on 2012-01-27

Patient: 76 year old female, weighing 55.3 kg (121.7 pounds)

Reactions: Tinnitus, Head Discomfort, Hypersensitivity, Pain in Extremity, Nasal Discomfort, Drug Ineffective, Upper-Airway Cough Syndrome, Oropharyngeal Pain, Dyspepsia, DRY Throat, DRY Mouth, Musculoskeletal Stiffness, DRY Eye, Transient Ischaemic Attack

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Unspecified Medication
    Start date: 2011-01-01
    End date: 2011-01-01

Claritin-D
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Nystatin
    Dosage: one teaspoon every six hours
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Unspecified Allergy Tablet
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Centrum Silver Ultra Women's
    Dosage: daily
    Administration route: Oral
    Indication: Vitamin Supplementation
    Start date: 2011-04-01
    End date: 2011-11-01

Claritin
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Unspecified Nose Spray
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Prilosec
    Dosage: two times a day
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Hydrogen Peroxide Solution
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Other drugs received by patient: Lunesta



Possible Nystatin side effects in 76 year old female

Reported by a individual with unspecified qualification from United States on 2012-01-03

Patient: 76 year old female, weighing 55.3 kg (121.7 pounds)

Reactions: Head Discomfort, Tinnitus, Hypersensitivity, Drug Ineffective, Pain in Extremity, Oropharyngeal Pain, Dyspepsia, DRY Throat, DRY Mouth, Musculoskeletal Stiffness, Transient Ischaemic Attack

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Centrum Silver Ultra Women's
    Dosage: daily
    Administration route: Oral
    Indication: Medical Diet
    Start date: 2011-04-01
    End date: 2011-11-01

Hydrogen Peroxide Solution
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Nystatin
    Dosage: one teaspoon every six hours
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Unspecified Nose Spray
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Unspecified Medication
    Start date: 2011-01-01
    End date: 2011-01-01

Claritin
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Prilosec
    Dosage: two times a day
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-01-01

Unspecified Allergy Tablet
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Claritin-D
    Administration route: Oral
    Indication: Oropharyngeal Pain
    Start date: 2011-01-01

Other drugs received by patient: Lunesta



Possible Nystatin side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from Brazil on 2011-11-18

Patient: 34 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Hyperpyrexia, Bronchopneumonia, Wheezing, Pyrexia, Multi-Organ Failure, Oral Candidiasis, Pulmonary Congestion, Cough, Renal Failure Acute, Oxygen Saturation Decreased, Dyspnoea, Metabolic Acidosis, Maternal Exposure During Pregnancy, Respiratory Distress, Cardiogenic Shock, Agranulocytosis, Fungal Infection, Oliguria, Systemic Inflammatory Response Syndrome, Neutropenia, Fusarium Infection, Septic Shock, Leukopenia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Nitrofurantoin
    Indication: Infection Prophylaxis

Ganciclovir
    Indication: Fusarium Infection

Nystatin
    Administration route: Oral
    Indication: Fusarium Infection

Amphotericin B

Ceftriaxone

Nystatin
    Administration route: Oral

Metamizole Sodium
    Indication: Tracheobronchitis

Ceftriaxone
    Indication: Pyelonephritis

Ceftriaxone
    Indication: Tracheobronchitis

Ceftriaxone

Clarithromycin
    Indication: Fusarium Infection

Imipenem
    Indication: Tracheobronchitis

Imipenem

Propranolol HCL
    Indication: Mitral Valve Stenosis

Furosemide
    Indication: Pulmonary Congestion

Nystatin
    Administration route: Oral
    Indication: Tracheobronchitis

Imipenem
    Indication: Fusarium Infection

Ganciclovir

Vancomycin
    Indication: Tracheobronchitis

Clarithromycin
    Indication: Tracheobronchitis

Vancomycin

Clarithromycin

Ganciclovir
    Indication: Tracheobronchitis

Vancomycin
    Indication: Fusarium Infection

Amphotericin B
    Indication: Tracheobronchitis

Amphotericin B
    Indication: Fusarium Infection

Other drugs received by patient: Oxytocin; Dobutamine HCL; Vitamin TAB; Sodium Chloride; Nitric Oxide



Possible Nystatin side effects in female

Reported by a individual with unspecified qualification from United States on 2011-11-09

Patient: female, weighing 86.0 kg (189.2 pounds)

Reactions: Stomatitis, Oesophagitis, Hypomagnesaemia, Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Paclitaxel
    Dosage: over 1 hour on day 1 of weeks 1-12 (cycle: 19 weeks)
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: over 5-30 min on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose:2334 mg
    Indication: Breast Cancer

Nystatin
    Indication: Product Used FOR Unknown Indication

Doxorubicin HCL
    Dosage: over 5-10 mins on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose: 234 mg
    Indication: Breast Cancer

Avastin
    Dosage: over 30-90 min on day 1 of weeks 1, 3, 5, 7, 9, 11, 13, 15 and 17 (cycle: 19 weeks); last date of ad
    Indication: Breast Cancer

Docusate Sodium
    Indication: Product Used FOR Unknown Indication

Hydromorphone HCL
    Indication: Product Used FOR Unknown Indication

Carboplatin
    Dosage: auc 6 over 30 min on day 1 of weeks 1, 4, 7 and 10 .cycle: 19 weeks, total dose:3600 mg
    Indication: Breast Cancer

Prochlorperazine
    Indication: Product Used FOR Unknown Indication

Lorazepam
    Indication: Product Used FOR Unknown Indication

Mouthwash NOS
    Indication: Product Used FOR Unknown Indication

Omeprazole
    Indication: Product Used FOR Unknown Indication



Possible Nystatin side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from Brazil on 2011-11-04

Patient: 34 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Pulmonary Hypertension, Hypovolaemic Shock, Agitation, Oligohydramnios, Bronchopneumonia, Pulmonary Embolism, Tricuspid Valve Incompetence, Cardiomegaly, Caesarean Section, Oral Candidiasis, Bronchopulmonary Aspergillosis, Pulmonary Necrosis, Metabolic Acidosis, Cytomegalovirus Test Positive, Parvovirus B19 Test Positive, Hypotension, Kidney Fibrosis, Bone Marrow Oedema, Maternal Exposure During Pregnancy, Respiratory Distress, Convulsion, Depressed Level of Consciousness, Premature Delivery, Aortic Valve Incompetence, Septic Shock, Multi-Organ Failure, Postpartum Sepsis, Pulmonary Congestion, Bone Marrow Failure, Renal Failure Acute, Tracheobronchitis, Renal Tubular Atrophy, Febrile Neutropenia, Cardiogenic Shock, Agranulocytosis, Cardiac Arrest, Mitral Valve Stenosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Vancomycin HCL

Propranolol
    Dosage: 40 mg, 2x/day

Dipyrone TAB

Nystatin

Ceftriaxone Sodium
    Dosage: 2 g, 1x/day
    Indication: Pyelonephritis

Ganciclovir

Clarithromycin

Furosemide
    Dosage: 40 mg, 2x/day

Macrodantin
    Indication: Prophylaxis

Imipenem

Ceftriaxone Sodium
    Indication: Tracheobronchitis

Other drugs received by patient: Nitric Oxide; Oxytocin



Possible Nystatin side effects in 34 year old female

Reported by a health professional (non-physician/pharmacist) from Brazil on 2011-11-02

Patient: 34 year old female, weighing 56.0 kg (123.2 pounds)

Reactions: Agitation, Pulmonary Hypertension, Oligohydramnios, Bronchopneumonia, Lung Infection, Rales, Pulmonary Embolism, Tricuspid Valve Incompetence, Pyrexia, Cardiomegaly, Caesarean Section, Oral Candidiasis, Cardiac Failure Congestive, Cough, Bronchopulmonary Aspergillosis, Pulmonary Necrosis, Metabolic Acidosis, Parvovirus B19 Test Positive, Cytomegalovirus Test Positive, Maternal Exposure During Pregnancy, Kidney Fibrosis, Bone Marrow Oedema, General Physical Health Deterioration, Respiratory Distress, Convulsion, NO Therapeutic Response, Depressed Level of Consciousness, Systemic Inflammatory Response Syndrome, Neutropenia, Premature Delivery, Aortic Valve Incompetence, Septic Shock, Wheezing, Pallor, Multi-Organ Failure, Postpartum Sepsis, Pulmonary Congestion, Bone Marrow Failure, Renal Failure Acute, Oxygen Saturation Decreased, Tracheobronchitis, Renal Tubular Atrophy, Odynophagia, Cardiogenic Shock, Agranulocytosis, Intestinal Dilatation, Heart Rate Increased, Oliguria, Blood Pressure Decreased, Cardiac Arrest, Leukocytosis, Leukopenia, Localised Intraabdominal Fluid Collection, Mitral Valve Stenosis

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Propranolol
    Dosage: 80 mg (40 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Furosemide
    Dosage: 80 mg (40 mg, 2 in 1 d)
    Indication: Product Used FOR Unknown Indication

Macrodantin
    Indication: Prophylaxis

Dipyrone INJ
    Indication: Product Used FOR Unknown Indication

Nystatin
    Indication: Product Used FOR Unknown Indication

Clarithromycin
    Indication: Product Used FOR Unknown Indication

Vancomycin
    Indication: Product Used FOR Unknown Indication

Ceftriaxone
    Dosage: intramuscular, (2 gm, 1 d), intramuscular
    Indication: Tracheobronchitis

Ceftriaxone
    Dosage: intramuscular, (2 gm, 1 d), intramuscular
    Indication: Pyelonephritis

Imipenem (Imipenem)
    Indication: Product Used FOR Unknown Indication

Ganciclovir
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Oxytocin; Nitric Oxyde (Nitric Oxyde)



Possible Nystatin side effects in female

Reported by a individual with unspecified qualification from United States on 2011-10-31

Patient: female, weighing 86.0 kg (189.2 pounds)

Reactions: Stomatitis, Oesophagitis, Hypomagnesaemia, Anaemia, Febrile Neutropenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Avastin
    Dosage: over 30-90 min on day 1 of weeks 1, 3, 5, 7, 9, 11, 13, 15 and 17 (cycle: 19 weeks); last date of ad
    Indication: Breast Cancer

Paclitaxel
    Dosage: over 1 hour on day 1 of weeks 1-12 (cycle: 19 weeks)
    Indication: Breast Cancer

Carboplatin
    Dosage: auc 6 over 30 min on day 1 of weeks 1, 4, 7 and 10 .cycle: 19 weeks, total dose:3600 mg
    Indication: Breast Cancer

Cyclophosphamide
    Dosage: over 5-30 min on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose:2334 mg
    Indication: Breast Cancer

Hydromorphone Hydrochloride
    Indication: Product Used FOR Unknown Indication

Omeprazole
    Indication: Product Used FOR Unknown Indication

Lorazepam
    Indication: Product Used FOR Unknown Indication

Mouthwash NOS
    Indication: Product Used FOR Unknown Indication

Nystatin
    Indication: Product Used FOR Unknown Indication

Docusate Sodium
    Indication: Product Used FOR Unknown Indication

Prochlorperazine
    Indication: Product Used FOR Unknown Indication

Doxorubicin HCL
    Dosage: over 5-10 mins on day 1 of weeks 13, 15, 17 and 19. cycle: 19 weeks.total dose: 234 mg
    Indication: Breast Cancer

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012